HeartGPS: Prenatal mental health support for mothers of babies with CHD
Official title: BOND HeartGPS: A Longitudinal Randomized Controlled Trial Examining the Maternal and Infant Effects of a Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
Run by Carelon Research · NCT07582861 · Data updated 2026-11-12
A pregnant person or mother of a baby with congenital heart disease will try a virtual mental health program (HeartGPS) in addition to standard care to see if it helps with well‑being and infant development.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Carelon Research Academic / other |
| Locations | 17 sites (Phoenix, Arizona and 16 other locations) |
| Status | Recruiting |
| Started | July 22, 2026 |
| Main results expected | July 2029 |
| Study ends | August 2030 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07582861 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant individuals or mothers of a fetus/newborn with CHD, expecting/facing surgery within 30 days of birth, with singleton pregnancy and English or Spanish proficiency.
✕Probably not a fit
Participants for whom the intervention is poorly matched to needs, or who have conditions preventing engagement, may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is part of the BOND platform, a randomized trial testing a prenatally started, online psychological intervention added to usual care for families affected by CHD. Eligible participants include pregnant individuals carrying a fetus with CHD or mothers of newborns with CHD who will need surgical or catheter-based treatment in the first month. The trial uses a two‑arm design to compare usual care alone versus usual care plus HeartGPS, with outcomes focused on maternal mental health and infant development. It is conducted at three children’s hospitals in the U.S., with English or Spanish language options for participation. The intervention is delivered virtually and aims to support parent wellbeing during the prenatal and early postnatal period.
Why it matters
Potential benefit: If successful, HeartGPS could improve maternal mental health and potentially support healthier early development for infants with CHD.
How similar studies have gone: Prior research in CHD familyWellbeing has shown benefits from psychosocial support; this study tests a prenatal, digitally delivered approach within a platform trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Both mothers and infants are study participants. Inclusion Criteria: 1. Pregnant individual carrying a fetus diagnosed with CHD or biological mother of an infant diagnosed with CHD in the neonatal period. 2. Fetus or newborn with CHD anticipated to require cardiac surgery or transcatheter intervention in the first 30 days of life. 3. CHD diagnosis received between 16.0 and 30.0 weeks gestation. 4. Singleton pregnancy. 5. Pregnant mother is planning to continue the pregnancy and pursue surgical or transcatheter intervention for the infant. 5\. Pregnant mother is able to participate and complete study assessments in English or Spanish. Exclusion Criteria: 1. Mother, fetal, or infant medical condition determined by a treating clinician to be contraindicative to study participation. 2. Mother with a severe, untreated psychiatric condition, substance use disorder, or other circumstances that, in the opinion of the investigator, would interfere with engagement with study tasks or safe participation in the trial. 3. Mother with a moderate to severe intellectual disability or is otherwise unable to provide informed consent. 4. Postnatal diagnosis of CHD. 5. Fetus with a comorbid condition with a predictable and major impact on neurodevelopment (e.g., Trisomy 21, DiGeorge syndrome). 6. Pregnant individual is aged \<18 years. 7. Pregnant individual is carrying a surrogate pregnancy. 8. Consented mother completes \<70% of survey questions at first (baseline) assessment.
Where it's running
-
Children's Healthcare of Atlanta
Atlanta, Georgia, United States Recruiting -
University of Michigan Health System, Ann Arbor
Ann Arbor, Michigan, United States Recruiting -
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Le Bonheur Children's Hospital
Memphis, Tennessee, United States Recruiting -
Phoenix Children's Hospital
Phoenix, Arizona, United States Not yet recruiting
Show 11 more locations
-
Children's Hospital of Los Angeles
Los Angeles, California, United States Not yet recruiting -
Children's Hospital Colorado
Aurora, Colorado, United States Not yet recruiting -
Lurie Children's Hospital
Chicago, Illinois, United States Not yet recruiting -
Golisano Children's at UK
Lexington, Kentucky, United States Not yet recruiting -
Boston Children's Hospital
Boston, Massachusetts, United States Not yet recruiting -
Children's Mercy Hospital
Kansas City, Missouri, United States Not yet recruiting -
Washington University School of Medicine
St Louis, Missouri, United States Not yet recruiting -
Icahn School of Medicine at Mount Sinai
New York, New York, United States Not yet recruiting -
Children's Hospital of New York
New York, New York, United States Not yet recruiting -
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States Not yet recruiting -
Primary Children's Medical Center
Salt Lake City, Utah, United States Not yet recruiting
Study contacts
- Study coordinator: Stephanie Lynch, MPH
- Email: stephanie.lynch@carelon.com
- Phone: 339-368-9294
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving transition of congenital heart disease care from pediatric to adult services
This program will try a multi-step transfer process to reduce health declines in people with congenital heart disease who are waiting to see an adult specialist.
-
Direct breastfeeding to support babies with congenital heart disease and their families
This study tests a breastfeeding-focused program to help infants with CHD breastfeed directly and see how it affects infant health and parental well-being.
-
Music and Multisensory Interventions for Pain During Chest Tube Removal in Infants with Congenital Heart Disease
This trial tests whether music or a multisensory mobile intervention can reduce pain and stabilize physiology during chest tube removal in 2- to 12-month-old infants with congenital heart disease.
-
MedlyPeds: a smartphone app to monitor kids with heart disease
This study tests whether the MedlyPeds app can help kids with heart conditions and their families stay informed and track symptoms remotely.
-
Fontan outcomes with low versus high lung blood flow in single‑ventricle hearts
This project will test whether people with single‑ventricle congenital heart disease who have reduced versus increased pulmonary blood flow do better or worse after the Fontan operation.
-
Coughing exercises versus incentive spirometry for breathing recovery after pediatric heart surgery
This study will test whether coughing exercises or incentive spirometry help children aged 6–18 recover their breathing and lung function after heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.